Only 1/71 (1.4%) patient in this study experienced recurrent thrombocytopenia and thrombosis despite anticoagulation, and this patient also tested positive for platelet-activating anti-PF4 antibodies, likely representing a case of persisting VITT [80]. Here, PF4 is linked to deep vein thrombosis.